Skip to main content
SpringerLink
Log in

Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Abedalthagafi MS, Bi WL, Merrill PH, Gibson WJ, Rose MF, Du Z et al (2015) ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genet 208:345–350. https://doi.org/10.1016/j.cancergen.2015.03.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Avninder S, Vermani S, Shruti S, Chand K (2007) Papillary meningioma: a rare but distinct variant of malignant meningioma. Diagn Pathol 2:3. https://doi.org/10.1186/1746-1596-2-3

    Article  PubMed  PubMed Central  Google Scholar 

  3. Biegel JA, Busse TM, Weissman BE (2014) SWI/SNF chromatin remodeling complexes and cancer. Am J Med Genet C Semin Med Genet 166C:350–366. https://doi.org/10.1002/ajmg.c.31410

    Article  CAS  PubMed  Google Scholar 

  4. Collord G, Tarpey P, Kurbatova N, Martincorena I, Moran S, Castro M et al (2018) An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Sci Rep 8:13537. https://doi.org/10.1038/s41598-018-31659-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D et al (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39:D945–950. https://doi.org/10.1093/nar/gkq929

    Article  CAS  PubMed  Google Scholar 

  6. Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J et al (2013) Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31:1023–1031. https://doi.org/10.1038/nbt.2696

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. He J, Abdel-Wahab O, Nahas MK, Wang K, Rampal RK, Intlekofer AM et al (2016) Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. Blood 127:3004–3014. https://doi.org/10.1182/blood-2015-08-664649

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hojo H, Abe M (2001) Rhabdoid papillary meningioma. Am J Surg Pathol 25:964–969. https://doi.org/10.1097/00000478-200107000-00018

    Article  CAS  PubMed  Google Scholar 

  9. Kros JM, Cella F, Bakker SL, Paz YGD, Egeler RM (2000) Papillary meningioma with pleural metastasis: case report and literature review. Acta Neurol Scand 102:200–202. https://doi.org/10.1034/j.1600-0404.2000.102003200.x

    Article  CAS  PubMed  Google Scholar 

  10. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  Google Scholar 

  11. Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ et al (2018) Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science 359:801–806. https://doi.org/10.1126/science.aan5951

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pasquier B, Gasnier F, Pasquier D, Keddari E, Morens A, Couderc P (1986) Papillary meningioma. Clinicopathologic study of seven cases and review of the literature. Cancer 58:299–305. https://doi.org/10.1002/1097-0142(19860715)58:2%3c299:aid-cncr2820580215%3e3.0.co;2-w

    Article  CAS  PubMed  Google Scholar 

  13. Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA (2005) INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 18:951–958. https://doi.org/10.1038/modpathol.3800375

    Article  CAS  PubMed  Google Scholar 

  14. Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM et al (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol 19:535–545. https://doi.org/10.1093/neuonc/now235

    Article  CAS  PubMed  Google Scholar 

  15. Shankar GM, Santagata S (2017) BAP1 mutations in high-grade meningioma: implications for patient care. Neuro Oncol 19:1447–1456. https://doi.org/10.1093/neuonc/nox094

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Smith MJ, O'Sullivan J, Bhaskar SS, Hadfield KD, Poke G, Caird J et al (2013) Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet 45:295–298. https://doi.org/10.1038/ng.2552

    Article  CAS  PubMed  Google Scholar 

  17. Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P et al (2011) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469:539–542. https://doi.org/10.1038/nature09639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Wadt KA, Aoude LG, Johansson P, Solinas A, Pritchard A, Crainic O et al (2015) A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clin Genet 88:267–272. https://doi.org/10.1111/cge.12501

    Article  CAS  PubMed  Google Scholar 

  19. Wang DJ, Zheng MZ, Gong Y, Xie Q, Wang Y, Cheng HX et al (2013) Papillary meningioma: clinical and histopathological observations. Int J Clin Exp Pathol 6:878–888

    PubMed  PubMed Central  Google Scholar 

  20. Wang H, Qu Y, Dai B, Zhu Y, Shi G, Zhu Y et al (2017) PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway. PLoS ONE 12:e0180862. https://doi.org/10.1371/journal.pone.0180862

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Author notes

  1. Daniel P. Cahill, Shakti H. Ramkissoon, and Tareq A. Juratli contributed equally to this work as co-senior authors.

Authors and Affiliations

  1. Foundation Medicine Inc, 150 Second Street, Cambridge, MA, 02141, USA

    Erik A. Williams, Ethan S. Sokol, Dean C. Pavlick, Nikunj Shah, Abhinav Reddy, Jeffrey M. Venstrom, Brian M. Alexander, Jeffrey S. Ross & Shakti H. Ramkissoon

  2. Translational Neuro‑Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

    Hiroaki Wakimoto, Daniel P. Cahill & Tareq A. Juratli

  3. Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

    Ganesh M. Shankar, Fred G. Barker II & Daniel P. Cahill

  4. Stephen E. and Catherine Pappas Center for Neuro-Oncology, Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Priscilla K. Brastianos

  5. Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA

    Sandro Santagata

  6. Department of Pathology, State University of New York Upstate Medical University, Syracuse, NY, USA

    Jeffrey S. Ross

  7. Wake Forest Comprehensive Cancer Center, Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Shakti H. Ramkissoon

  8. Department of Neurosurgery, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

    Tareq A. Juratli

Authors
  1. Erik A. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroaki Wakimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ganesh M. Shankar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fred G. Barker II
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Priscilla K. Brastianos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sandro Santagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ethan S. Sokol
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dean C. Pavlick
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nikunj Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Abhinav Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jeffrey M. Venstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Brian M. Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jeffrey S. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Daniel P. Cahill
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Shakti H. Ramkissoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Tareq A. Juratli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erik A. Williams.

Ethics declarations

Conflict of interest

EAW, ESS, DCP, NS, AR, JMV, BMA, JSR, and SHR are employees or consultants of Foundation Medicine, Inc., a wholly owned subsidiary of Roche Holdings, Inc. and Roche Finance Ltd, and these employees have equity interest in an affiliate of these Roche entities. SS is a consultant for RareCyte. PKB reports honoraria for consulting from Tesaro, Lilly, Angiochem, and Genentech‐Roche; speaker's honoraria from Genentech‐Roche and Merck; and research funding (to Massachusetts General Hospital) from BMS, Pfizer, Lilly and Merck. DPC reports receiving honoraria from Merck and Lilly outside the submitted work.

IRB approval status

Reviewed and approved by Western IRB; Protocol no. 20152817.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 11 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, E.A., Wakimoto, H., Shankar, G.M. et al. Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features. Acta Neuropathol 140, 89–93 (2020). https://doi.org/10.1007/s00401-020-02161-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-020-02161-7

Search

Navigation